Job Title: Associate Director, Global Payer Value & Access (PVA) – Vaccines
Duration: 1 year initially
Pay range: $65-85/hr (flexible based on experience).
Location: Remote
Job Summary:
The Associate Director, Global Payer Value & Access (PVA) – Vaccines will drive global pricing, reimbursement, and market access strategies to maximize the value of Qdenga across key markets. This role also supports commercial technology transfer and local manufacturing assessments to enhance affordability and market access.
The position focuses on:
- Optimizing pricing models
- Ensuring price compliance
- Maintaining pricing platforms for audit purposes
- Enhancing payer value propositions aligned with affordability, sustainability, and public health priorities
The role requires close collaboration with regional and local teams, Commercial, Medical, HEOR, and Public Affairs to secure sustainable market access throughout Qdenga’s lifecycle.
Key Responsibilities:
1. Global Pricing Strategy & Compliance
- Refine global pricing and reimbursement strategies to balance affordability, value, and sustainability across diverse markets.
- Define payer segmentation and pricing frameworks for procurement channels including PAHO Revolving Fund, GAVI, UNICEF, national tendering systems, and private markets.
- Conduct pricing scenario analyses considering competitor entry, tendering strategies, and volume-based contracting.
- Ensure price compliance across markets in alignment with global pricing policies and regulatory requirements.
- Maintain and update pricing platforms for accuracy and audit-readiness.
2. Pricing Strategy, Life Cycle Management & Competitive Positioning
- Refine lifecycle pricing strategies considering multi-dose vials, new evidence, and policy shifts (e.g., WHO recommendations).
- Monitor global market trends, competitor pricing, and policy shifts impacting vaccine access (e.g., HTA policy changes).
- Support regional teams in adapting pricing and access strategies for new market entrants, evolving public procurement mechanisms, and changes in government funding.
3. Regional & Local Support in Execution of Pricing and Access Strategies
- Guide regional and local teams to execute pricing strategies aligned with local payer dynamics and global objectives.
- Provide strategic input on tender participation, volume-based agreements, and innovative pricing models (e.g., risk-sharing agreements).
- Localize value narratives and health economic models to strengthen reimbursement submissions and payer negotiations.
- Facilitate knowledge-sharing and capability-building to enhance local teams’ pricing and payer engagement expertise.
- Support local advisory boards to gather payer and policymaker insights for refining pricing and value communication.
4. Data & Digital-Driven Access Perspective
- Leverage digital platforms and value communication tools (e.g., Dengue.com) to enhance payer engagement.
- Utilize AI-driven pricing analytics, real-world data (RWD), and forecasting models to optimize access strategies and anticipate procurement and reimbursement trends.
5. Technology Transfer & Local Manufacturing Assessments
- Support technology transfer initiatives and local manufacturing assessments to enhance affordability and market access.
- Evaluate pricing and access implications of local production, including cost structures, scalability, and alignment with global pricing strategies.
- Collaborate with cross-functional teams to assess the feasibility and impact of technology transfer agreements on market access and sustainability.
Ad Hoc Support:
1. Payer Value Proposition Development & Execution
- Refine Global Value Dossiers (GVDs), payer negotiation toolkits, objection-handling materials, and other tools to support local market access and pricing teams.
- Ensure alignment of clinical, economic, and public health value messaging with payer needs and policy priorities.
- Collaborate with public affairs and policy teams to support funding advocacy, vaccine inclusion in national programs (NIPs), and health system strengthening initiatives.
2. Evidence Generation & HEOR Integration
- Partner with HEOR teams to design cost-effectiveness models, budget impact analyses, and real-world evidence (RWE) strategies.
- Shape post-launch RWE initiatives to ensure long-term pricing sustainability and policy support.
Key Qualifications & Experience:
- Advanced degree in health economics, public health, business, pharmacy, or related field (MBA, MSc, MPH, PharmD preferred)
- 5+ years of experience in Pricing and Access with a focus on vaccines
- Strong understanding of global vaccine reimbursement frameworks, public procurement dynamics, and multi-lateral funding mechanisms (e.g., GAVI, PAHO, UNICEF, national HTA agencies, NIPs)
- Proven ability to engage payers, policymakers, and health system stakeholders to shape vaccine access policies
- Experience in emerging markets with direct exposure to vaccine pricing and reimbursement negotiations
- Excellent communication skills; able to influence cross-functional teams across global, regional, and country levels
Beneficial:
- Experience with PDP agreements, tech transfer pricing models, and innovative access strategies
- Background in volume-based agreements, tiered pricing, and alternative financing mechanisms for vaccines
- Familiarity with health system financing and procurement models in LMICs
Travel Requirements:
- Limited travel required to ensure execution excellence and optimize stakeholder engagement
This is an equal opportunities employer.